HI
DXCM icon

Humankind Investments’s DexCom DXCM Stock Holding History

Humankind Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,370
Closed -$227K – 68
2025
Q3 		$227K Buy
3,370
+313
+10% +$24.8K 0.05% 138
2025
Q2 		$267K Buy
+3,057
New +$240K 0.07% 121
2025
Q1 		– Sell
-2,830
Closed -$220K – 152
2024
Q4 		$220K Buy
+2,830
New +$210K 0.06% 137

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Humankind Investments's DXCM Position: Q4 2025 in Review

Humankind Investments sold out of DexCom (DXCM) in Q4 2025, closing a stake of 3,370 shares — an estimated $227K sold.

Humankind Investments first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $267K in Q2 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Humankind Investments reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 3,370 DexCom shares in Q4 2025, an estimated $227K.
  • Humankind Investments first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Humankind Investments's DexCom position peaked at $267K in Q2 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.